Teva Attacks Watson Over Generic Menopause Drug
Teva Women's Health Inc. has filed a patent infringement suit over Watson Pharmaceuticals Inc.'s plan to introduce a generic version of menopause drug Cenestin....To view the full article, register now.
Already a subscriber? Click here to view full article